Market News

Piper Sandler analyst Paul Newsome maintains Lemonade (NYSE:LMND) with a Neutral and lowers the price target from $51 to $47.

The changes were announced alongside Celsius Holdings’ third-quarter results, which highlighted contrasting performances across its three core brands.

Trustmark has delivered a strong share price run in recent years, which puts fresh attention on what the bank actually earns on the capital it puts to...

Cardinal Health reported first quarter fiscal 2027 results for the period ended September 30, 2026, with sales of US$67.513b, net income of US$554m, a...

Skyward Specialty Insurance Group has had a strong run, and the share price performance has pushed investors to ask whether the current level is still...

Wells Fargo analyst Noah Hungness maintains Permian Resources (NYSE:PR) with a Overweight and lowers the price target from $28 to $27.

John Wiley & Sons recently expanded its Advanced Portfolio by launching four open access journals: Advanced City, Advanced Food, Advanced Microbiome, ...

With average life expectancy across the EU now exceeding 81 years, Principal Financial chief executive Deanna Strable argues employers must rethink ca...

The analyst fair value estimate for Stewart Information Services has been trimmed from US$76.25 to US$69.75, which points to a lower price target zone...

-CNBC.

Piper Sandler analyst Michael Lavery maintains Molson Coors Beverage (NYSE:TAP) with a Neutral and lowers the price target from $44 to $43.

Power Solutions International reported third quarter 2026 net sales of US$202.1 million and net income of US$29.9 million, with record operating incom...

Addus HomeCare reported third quarter 2026 net income of US$28.59 million and diluted EPS from continuing operations of US$1.54, compared with US$22.8...

Aurinia Pharmaceuticals reported third quarter 2026 revenue of US$83.7 million and net income of US$31.7 million, with nine month revenue of US$244.62...

GE Aerospace (NYSE:GE) has outperformed the market over the past 5 years by 25.94% on an annualized basis producing an average annual return of 35.36%...

Bloomin Brands (NASDAQ:BLMN) reported third-quarter financial results on Friday. The transcript from the company’s third-quarter earnings call has bee...

Keybanc analyst Paul Knight maintains Castle Biosciences (NASDAQ:CSTL) with a Overweight and raises the price target from $35 to $40.

Piper Sandler analyst Michael Lavery maintains Monster Beverage (NASDAQ:MNST) with a Overweight and raises the price target from $50.5 to $53.

D-Wave Quantum (QBTS) just rolled out a major upgrade to its Stride hybrid solver, with benchmark tests showing much faster, higher quality optimizati...

Axon missed Q3 revenue and earnings estimates, cut FY26 guidance, and shares fell 14%; analysts lowered price targets.